2025 annual financial data
Aclaris Therapeutics 2025 Operating margin
Direct answer
Operating margin was -975.91%.
Operating income was -76,375,000 USD and net income was -64,923,000 USD.
Operating cash flow was -47,113,000 USD.
Get free Aclaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,826,000 USD
- Operating income
- -76,375,000 USD
- Net income
- -64,923,000 USD
- Operating cash flow
- -47,113,000 USD